Mark S. Kleven - Concepedia

Author

Mark S. Kleven

Also Known As

M KLEVEN, M S KLEVEN, M S Kleven, M. Kleven, M. S. Kleven, M.S. Kleven, MARK S. KLEVEN, MS Kleven, Mark Kleven, Mark S Kleven

110

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Pierre Fabre (France)University of Chicago Pierre Fabre (Germany)Department of Physiological Sciences Inserm

About

Mark S. Kleven is an author at Pierre Fabre (France) specializing in medicine, neuropharmacology, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	2.1K
2	Social Sciences	25	34	1.9K
3	Health Sciences	7	7	242
4	Anesthesia	2	2	35
5	Public Health	1	1	27

Mark S. Kleven

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. Mark S. Kleven, Ekechi Anthony, W. L. Woolverton Journal of Pharmacology and Experimental Therapeutics	1990	177
Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain Mark S. Kleven, Bruce D. Perry, William L. Woolvertom, Brain Research Substance AbusePsychoactive DrugPsychiatryNeurophysiologyAddiction	1990	155
Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. Mark S. Kleven, Wouter Koek Journal of Pharmacology and Experimental Therapeutics	1996	134
Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey Gail Farfel, Mark S. Kleven, William L. Woolverton, Brain Research PsychopharmacologyCocaineSocial SciencesRepeated InjectionsPsychoactive Drug	1992	120
Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the rat L. A. Bruins Slot, Mark S. Kleven, Adrian Newman‐Tancredi Neuropharmacology PsychiatryBehavioral NeuroscienceNovel AntipsychoticsPsychopharmacologySchizophrenia	2005	114
Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine Mark S. Kleven, William L. Woolverton, Lewis S. Seiden Brain Research Bulletin Substance AbusePsychoactive DrugSubstance UsePsychopathologyLong-term Monoamine Depletions	1988	109
Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT<sub>1A</sub> Receptors Bernard Vacher, Bernard Bonnaud, Philippe Funes, Journal of Medicinal Chemistry	1999	107
F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair, The International Journal of Neuropsychopharmacology In-vivo ProfileNeurotransmitterPsychopharmacologyExperimental PharmacologySocial Sciences	2010	106
Antipsychotic-Like vs Cataleptogenic Actions in Mice of Novel Antipsychotics Having D2 Antagonist and 5-HT1A Agonist Properties Laurent Bardin, Mark S. Kleven, Catherine Barret-Grévoz, Neuropsychopharmacology PsychiatryFunctional SelectivityMedicinePsychopharmacologyNeuropharmacology	2005	104
Novel antipsychotic agents with 5-HT agonist properties: Role of 5-HT receptor activation in attenuation of catalepsy induction in rats Mark S. Kleven, L. A. Bruins Slot, Adrian Newman‐Tancredi Neuropharmacology PsychiatryNeurophysiologyBehavioral NeuroscienceMedicinePsychotropic Medication	2005	81

Page 1